New heart valve delivery system shows promise in 137-Patient trial
Disease control
Completed
This study tested a new system (IMPERIA) for delivering a replacement heart valve (ALLEGRA) in 137 people with severe aortic stenosis or a failed surgical valve. The main goal was to see if the valve was placed correctly and worked well 7 days after the procedure. The study focus…
Phase: NA • Sponsor: NVT GmbH • Aim: Disease control
Last updated May 26, 2026 11:02 UTC